View in EDS PDF Full Text

Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.

Saved in:
Bibliographic Details
Title: Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.
Authors: Hu, Shuyi1, Wu, Zipeng1, Dai, Yingying2, Shi, Xinhong1, Hu, Qin1, Liu, Caolu2, Yifei Zhu1, Ruofan Yu1, Jingwen Li1, Ying Liu1, Tianyi Liu2, Lin Lu2, Chengyun Yao2, Bo Shen1, Meiqi Shi1, Cheng Chen2,3 njmudoctor@163.com, Xiaohua Wang1 wangxiaohua@jszlyy.com.cn, Guoren Zhou1 zhouguoren888@163.com
Source: Cancer Biology & Medicine. Dec2025, Vol. 22 Issue 12, p1544-1552. 9p.
Database: Academic Search Ultimate
Description
ISSN:20953941
DOI:10.20892/j.issn.2095-3941.2025.0393